| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3866998 | The Journal of Urology | 2012 | 5 Pages |
Abstract
Adjuvant intravesical instillations of apaziquone are generally well tolerated. The recurrence rates of 34.7% after 12 months and 44.9% after 18 months in these patients can be considered encouraging, and warrant further study.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
K. Hendricksen, E.B. Cornel, T.M. de Reijke, H.C. Arentsen, S. Chawla, J.A. Witjes,